PET Imaging of Peripheral Nerve Tumors

被引:11
作者
Assadi, Majid [1 ]
Velez, Erik [2 ]
Najafi, Mohammad Hosein [3 ]
Matcuk, George [1 ]
Gholamrezanezhad, Ali [2 ]
机构
[1] Bushehr Univ Med Sci, Bushehr Med Univ Hosp, Persian Gulf Nucl Med Res Ctr, Dept Mol Imaging & Radionuclide Therapy MIRT, Moallem St, Bushehr 3631, Iran
[2] USC, Keck Sch Med, Dept Diagnost Radiol, 1520 San Pablo St,Suite L1600, Los Angeles, CA 90033 USA
[3] Azad Univ, Dept Cardiol, Tehran Med Unit, Shariati St, Tehran 1916893813, Iran
关键词
PET; Malignant peripheral nerve sheath tumor (MPSNT); PET/CT imaging; PET/MR imaging; POSITRON-EMISSION-TOMOGRAPHY; WHOLE-BODY MRI; SHEATH TUMORS; F-18-FDG PET/CT; NEUROFIBROMATOSIS TYPE-1; PRECISION MEDICINE; FDG-PET; PET/COMPUTED TOMOGRAPHY; GA-68-DOTATATE PET/CT; NEOADJUVANT THERAPY;
D O I
10.1016/j.cpet.2018.08.013
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PET has been founded as a useful technique in the staging, restaging, prognostication, and treatment planning for numerus cancers, with an incremental application in precision oncology. This paper summarized the current state-of-the-art application of PET/CT in the management of patients with peripheral nerve tumors. Furthermore, the potential clinical uses of emerging themes and technological advances are reviewed, consisting hybrid PET/MR imaging and alternative radiotracers for the application in peripheral nerve oncology.
引用
收藏
页码:81 / +
页数:10
相关论文
共 70 条
[1]   Schwannoma of the extremities: the role of PET in preoperative planning [J].
Ahmed, AR ;
Watanabe, H ;
Aoki, J ;
Shinozaki, T ;
Takagishi, K .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10) :1541-1551
[2]  
[Anonymous], 2016, DIAGNOSTIC HISTOPATH, DOI 10.1016/j.mpdhp.2016.10.008
[3]   Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma [J].
Arush, M. Weyl Ben ;
Israel, O. ;
Postovsky, S. ;
Militianu, D. ;
Meller, I. ;
Zaidman, I. ;
Sapir, A. Even ;
Bar-Shalom, R. .
PEDIATRIC BLOOD & CANCER, 2007, 49 (07) :901-905
[4]  
Azizi AA, 2018, PEDIAT BLOOD CANC, V65, P1
[5]   PET-Based Personalized Management in Clinical Oncology An Unavoidable Path for the Foreseeable Future [J].
Basu, Sandip ;
Alavi, Abass .
PET CLINICS, 2016, 11 (03) :203-+
[6]   Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders [J].
Basu, Sandip ;
Kwee, Thomas C. ;
Gatenby, Robert ;
Saboury, Babak ;
Torigian, Drew A. ;
Alavi, Abass .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (06) :987-991
[7]   Positron emission tomography of schwannomas: Emphasizing its potential in preoperative planning [J].
Beaulieu, S ;
Rubin, B ;
Djang, D ;
Conrad, E ;
Turcotte, E ;
Eary, JF .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 182 (04) :971-974
[8]   Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas [J].
Benz, Matthias R. ;
Allen-Auerbach, Martin S. ;
Eilber, Fritz C. ;
Chen, Hui J. J. ;
Dry, Sarah ;
Phelps, Michael E. ;
Czernin, Johannes ;
Weber, Wolfgang A. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (10) :1579-1584
[9]   Quantitative F18-Fluorodeoxyglucose Positron Emission Tomography Accurately Characterizes Peripheral Nerve Sheath Tumors as Malignant or Benign [J].
Benz, Matthias R. ;
Czernin, Johannes ;
Dry, Sarah M. ;
Tap, William D. ;
Allen-Auerbach, Martin S. ;
Elashoff, David ;
Phelps, Michael E. ;
Weber, Wolfgang A. ;
Eilber, Fritz C. .
CANCER, 2010, 116 (02) :451-458
[10]   Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours [J].
Bradtmoeller, Maren ;
Hartmann, Christian ;
Zietsch, Jan ;
Jaeschke, Sebastian ;
Mautner, Victor-F ;
Kurtz, Andreas ;
Park, Su-Jin ;
Baier, Michael ;
Harder, Anja ;
Reuss, David ;
von Deimling, Andreas ;
Heppner, Frank L. ;
Holtkamp, Nikola .
PLOS ONE, 2012, 7 (11)